FDA Is Reportedly 'Taking A Hard Look'
Digest more
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on hormone treatments for menopause, arguing that the strong warning has likely discouraged countless women from using a treatment that may provide benefit.
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated.
20h
News Nation on MSNFDA chief: HRT warning among ‘greatest mistakes of modern medicine’( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the warnings printed on hormone replacement therapy products for menopausal women because the caution labels overstate the health risks.
12h
Axios on MSNFDA panel backs menopausal hormone therapyAn Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for menopause that critics say have discouraged women for decades from using the pills and creams.
1d
MedPage Today on MSNA 'Culture Change' Is Needed in Academic Medicine, FDA Commissioner SaysThe culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The Hill.
Explore more
1d
Agence France-Presse on MSNUS may revise hormone replacement therapy warningsUS Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels on Hormone Replacement Therapy, following testimony from experts who said the treatment's risks have long been exaggerated.
7don MSNOpinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's guidelines for saturated fats.